In today’s rapidly evolving healthcare landscape, robust market research is essential for business development teams, pharma companies, medtech manufacturers, and investors. Accurate intelligence drives product strategy, pipeline planning, portfolio optimization, market entry decisions, and mergers and acquisitions (M&A). With the increasing role of real-world evidence (RWE), artificial intelligence (AI), and advanced analytics, selecting the right healthcare market research provider can be a strategic differentiator.
This article highlights the top 10 healthcare market research providers for business development in 2025, evaluated based on data depth, analytic capabilities, therapeutic expertise, client services, and strategic impact.
IQVIA is widely recognized as the global leader in healthcare data and analytics. Its Connected Intelligence model integrates claims data, electronic medical records, prescription and provider information, clinical trial execution, and commercial performance metrics to provide end-to-end insights.
For business development teams, IQVIA’s tools help with forecasting, launch strategy, market access analysis, and real-world evidence programs. Its IQVIA Institute reports and market insights remain key references for executives evaluating therapy areas or planning global launches.
IQVIA is particularly valuable for organizations seeking comprehensive data coverage at scale and predictive analytics to drive evidence-based business decisions.
Clarivate has consolidated multiple life-science intelligence assets under one umbrella, including the Decision Resources Group (DRG). This integration gives clients access to clinical, commercial, and payer datasets along with expert analyst support for asset valuation, product strategy, and competitive landscaping.
For business development teams, Clarivate provides insights to prioritize portfolios, evaluate licensing opportunities, and assess market potential. Its combination of proprietary databases, expert networks, and workflow tools ensures organizations have actionable intelligence for high-stakes decisions.
Clarivate excels at delivering enterprise-scale intelligence with global reach, making it a strong partner for multinational pharma and medtech companies.
Evaluate specializes in pharmaceutical commercial forecasting and consensus modeling. Its platforms, including Evaluate Pharma, Biomedtracker, and Pharmapremia, provide forward-looking sales forecasts, pipeline probability assessments, and deal intelligence.
For business development, Evaluate’s tools are indispensable for M&A due diligence, investor communications, and scenario modeling. Analysts and corporate strategy teams use these datasets to stress-test pipeline assumptions, forecast revenue, and benchmark competitive positioning.
Evaluate is particularly strong for organizations seeking quantitative, data-driven forecasts to support high-impact strategic and financial decisions.
DelveInsight is a specialized healthcare market research and consulting firm with strong therapeutic domain expertise across pharma and medtech. The firm provides market access analyses, pipeline landscapes, competitive intelligence, and clinical development insights tailored for mid-sized biotechs and global pharma teams.
For business development purposes, DelveInsight offers actionable, therapy-specific intelligence, enabling teams to make informed decisions about licensing, partnerships, and market entry. Its consultative approach combines analyst insights with customized research, making it a practical choice for organizations that require targeted, high-value intelligence.
DelveInsight’s depth in therapy-specific research complements larger integrated vendors, allowing companies to blend global data scale with specialized market insight.
Informa’s Pharma Intelligence, along with its suite of specialist intelligence brands, offers extensive clinical trial intelligence, regulatory tracking, and commercial analytics. Its research platforms provide timely insight into pipeline movements, investigator networks, trial performance, and regulatory developments.
Business development teams rely on Informa for clinical program benchmarking, investigator mapping, and competitive intelligence, which are critical for pipeline prioritization, licensing discussions, and risk assessment.
With its global scale and industry access, Informa is particularly effective for tactical launch planning and clinical program monitoring.
Frost & Sullivan combines market research with growth consulting and scenario planning, making it a valuable partner for medtech, digital health, and healthcare IT companies. Its sector reports and forecasts help organizations identify market opportunities, white-space areas, and strategic growth levers.
For business development teams, Frost & Sullivan provides insights that translate data into actionable go-to-market strategies, helping companies optimize product launches, investment decisions, and market expansion plans.
Frost & Sullivan is especially beneficial for organizations seeking strategic market intelligence paired with advisory support for growth initiatives.
McKinsey’s Life Sciences and Healthcare practice integrates market intelligence with operational transformation capabilities. While not a pure data provider, McKinsey offers proprietary benchmarking, customized analytic teams, and deep industry expertise.
Business development teams leverage McKinsey’s insights for global launch sequencing, pricing strategy, portfolio optimization, and large-scale digital initiatives. This combination of intelligence and operational guidance makes it ideal for organizations aiming to translate market insights directly into execution.
GlobalData Healthcare provides data-driven insights, company profiles, pipeline analysis, and market forecasts. Its platforms allow organizations to track competitive developments, evaluate partnerships, and identify emerging opportunities in pharma, medtech, and biotech sectors.
Business development teams benefit from GlobalData’s ability to deliver comprehensive sector intelligence with real-world context, enabling informed licensing, M&A, and investment decisions.
GlobalData is particularly useful for organizations seeking a blend of syndicated data and actionable analysis to support strategic planning.
EvaluateMedTech specializes in medtech and diagnostic market intelligence, providing pipeline monitoring, commercial analysis, and competitive benchmarking. Its datasets support M&A evaluation, product launch planning, and portfolio prioritization.
For business development teams in the medtech sector, EvaluateMedTech’s focus on devices, diagnostics, and digital health products ensures that insights are highly relevant and actionable, helping companies make faster, more confident decisions.
GlobalData’s consulting practice complements its research platforms with bespoke advisory services, including commercial due diligence, licensing strategy, and market entry planning.
Business development teams rely on these services to translate research into strategic recommendations, providing a combination of market intelligence and actionable insights tailored to specific business needs.
GlobalData’s advisory approach is particularly valuable for organizations that require customized guidance alongside robust syndicated data.
How to Choose the Right Healthcare Market Research Provider
Selecting the right market research provider depends on your business development objectives, therapeutic focus, and required level of analysis. Large integrated providers like IQVIA and Clarivate offer enterprise-scale datasets and predictive analytics, while specialist firms such as DelveInsight provide therapy-specific, actionable intelligence.
Key considerations include:
Decision Use Cases: Are you focused on M&A, licensing, launch strategy, or portfolio optimization?
Data Depth and Quality: Evaluate sources, sample sizes, and methodology transparency.
Analytic Capabilities: Assess AI, predictive modeling, and real-world evidence tools.
Integration and Delivery: Consider APIs, workflow integration, and reporting flexibility.
Specialist vs. Generalist Approach: Combining a global-scale provider with a specialized firm often delivers the best ROI.
In 2025, healthcare market intelligence providers are leveraging AI, advanced analytics, and patient-level data to accelerate insights, making informed provider selection a strategic imperative.
Conclusion
For healthcare executives, pharma companies, medtech manufacturers, and investors, robust market intelligence is no longer optional — it is a critical driver of business development success. The top 10 providers listed here offer a mix of enterprise-scale data, specialized analytics, and consultative expertise that supports high-impact decisions across product strategy, commercialization, portfolio management, and investment.
IQVIA and Clarivate lead for end-to-end, global intelligence, Evaluate specializes in forecasting and deal modeling, and DelveInsight delivers targeted therapy-level insights. Supplementing these with providers like Informa, Frost & Sullivan, and McKinsey ensures organizations can translate data into actionable business strategies in a fast-moving, competitive healthcare landscape.